Literature DB >> 4683875

Hemoglobin olympia ( 20 valine leads to methionine): an electrophoretically silent variant associated with high oxygen affinity and erythrocytosis.

G Stamatoyannopoulos, P E Nute, J W Adamson, A J Bellingham, D Funk.   

Abstract

In a family with erythrocytosis, electrophoretic and chromatographic studies failed to demonstrate a hemoglobin variant. However, the oxygen dissociation curves of affected individuals were shifted to the left of normal and this shift persisted when oxygen equilibria were studied in 2.3-diphosphoglycerate-stripped hemolysates. A mutant hemoglobin was evidently present in the red blood cells of the affected persons and was responsible for the increased oxygen affinity and erythrocytosis. Specific staining of tryptic peptide maps of beta-chains from the propositus showed that peptide betaT(3) was positive for a sulfur-containing amino acid. Amino acid analysis yielded a composition identical to that of normal betaT(3), except that there were 2.6 residues of valine and 0.4 residues of methionine (normal composition: Val = 3.0, Met = 0). This suggested that the beta-chains of affected individuals consisted of a mixture of two kinds of chains, 40% of which had a methionyl residue in betaT(3). Structural studies of isolated cyanogen bromide fragments demonstrated unequivocally that, in the abnormal beta-chains, valine in position 20 is replaced by methionine. The new hemoglobin mutant is designated hemoglobin Olympia (beta20 (B2) valine --> methionine).

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4683875      PMCID: PMC302263          DOI: 10.1172/JCI107190

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  THE AMINO ACID COMPOSITION OF HEMOGLOBIN. 3. A QUALITATIVE METHOD FOR IDENTIFYING ABNORMALITIES OF THE POLYPEPTIDE CHAINS OF HEMOGLOBIN.

Authors:  A I CHERNOFF; N M PETTIT
Journal:  Blood       Date:  1964-12       Impact factor: 22.113

2.  A NEW METHOD FOR THE PREPARATION OF ALPHA AND BETA SUBUNITS OF HUMAN HEMOGLOBIN.

Authors:  E BUCCI; C FRONTICELLI
Journal:  J Biol Chem       Date:  1965-01       Impact factor: 5.157

3.  The use of chromium as red-cell tag.

Authors:  D M DONOHUE; A G MOTULSKY; E R GIBLETT; G PIRZIO-BIROLI; V VIRANUVATTI; C A FINCH
Journal:  Br J Haematol       Date:  1955-07       Impact factor: 6.998

4.  The amino-acid sequence in the phenylalanyl chain of insulin. I. The identification of lower peptides from partial hydrolysates.

Authors:  F SANGER; H TUPPY
Journal:  Biochem J       Date:  1951-09       Impact factor: 3.857

5.  The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation.

Authors:  J W Adamson
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

6.  Three dimensional fourier synthesis of horse deoxyhaemoglobin at 2.8 Angstrom units resolution.

Authors:  W Bolton; M F Perutz
Journal:  Nature       Date:  1970-11-07       Impact factor: 49.962

7.  Three-dimensional Fourier synthesis of human deoxyhaemoglobin at 3.5 Angstrom units.

Authors:  H Muirhead; J Greer
Journal:  Nature       Date:  1970-11-07       Impact factor: 49.962

8.  Hemoglobin Hiroshima (beta-143 histidine--aspartic acid): a newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia.

Authors:  H B Hamilton; I Iuchi; T Miyaji; S Shibata
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

9.  The oxygenation of hemoglobin in the presence of 2,3-diphosphoglycerate. Effect of temperature, pH, ionic strength, and hemoglobin concentration.

Authors:  R E Benesch; R Benesch; C I Yu
Journal:  Biochemistry       Date:  1969-06       Impact factor: 3.162

10.  Reciprocal binding of oxygen and diphosphoglycerate by human hemoglobin.

Authors:  R Benesch; R E Benesch; C I Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1968-02       Impact factor: 11.205

View more
  5 in total

1.  Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis.

Authors:  Melanie J Percy; Nauman N Butt; Gerard M Crotty; Mark W Drummond; Claire Harrison; Gail L Jones; Matthew Turner; Jonathan Wallis; Mary Frances McMullin
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

2.  Hemoglobin Syracuse (alpha2beta2-143(H21)His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins.

Authors:  M Jensen; F A Oski; D G Nathan; H F Bunn
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

3.  Hemoglobinopathic erythrocytosis due to a new electrophoretically silent variant, hemoglobin San Diego (beta109 (G11)val--met).

Authors:  P E Nute; G Stamatoyannopoulos; M A Hermodson; D Roth
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

4.  Hemoglobin brigham (alpha2Abeta2100 Pro--Leu). Hemoglobin variant associated with familial erythrocytosis.

Authors:  J J Lokich; W C Moloney; H F Bunn; S M Bruckheimer; H M Ranney
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

5.  Familial polycythaemia caused by a new haemoglobin variant: Hb Heathrow, beta 103 (G5) phenylalanine leads to leucine.

Authors:  J M White; L Szur; I D Gillies; P A Lorkin; H Lehmann
Journal:  Br Med J       Date:  1973-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.